-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies

Dow Jones·01/28/2025 12:00:00

Please log in to view news